- An
oncolytic virus is a
virus that
preferentially infects and
kills cancer cells. As the
infected cancer cells are destro**** by oncolysis, they release...
-
vector for gene
therapy and also as an
oncolytic virus. Of the many
different viruses being explored for
oncolytic potential, an
adenovirus was the first...
-
Oncolytics Biotech Inc. is a
Canadian company headquartered in Calgary, Alberta, that is
developing an
intravenously delivered immuno-
oncolytic virus...
-
treat diseases.
There are
three main
branches of virotherapy: anti-cancer
oncolytic viruses,
viral vectors for gene
therapy and
viral immunotherapy. These...
- such as ICP34.5, ICP6/UL39, and ICP47. HSV1716 is a
first generation oncolytic virus developed by the
Glasgow Institute of Virology, and subsequently...
-
lining every blood vessel,
making CD109 a poor
target for immunotherapy.
Oncolytic viral therapy is an
emerging cancer therapy that
attempts to
infect cancer...
- approaches:
individual therapeutic vaccines,
shared antigens cancer vaccines oncolytic viruses. Transgene’s
portfolio consists of four
products currently in...
-
systems could improve the
clinical benefit from
these types of therapies.
Oncolytic virotherapy is an
emerging novel treatment that is
under investigation...
- M,
Burnett JP (September 1963). "The
Vinca Alkaloids: A New
class of
Oncolytic Agents" (PDF).
Cancer Research. 23 (8 Part 1): 1390–427. PMID 14070392...
-
pipeline includes multiple immunotherapy B-cell
vaccine candidates and an
oncolytic virotherapy (CF33)
aimed at
treating a
variety of
cancers in combination...
